© 1994 Oxford University Press
research-article |
Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate
Chemical Industry Institute of Toxicology, Research Triangle Park NC 27709, USA
1Present address: Daiichi Pharmaceutical Co. Ltd. Tokyo, Japan
2Present address: Sterling Winthrop Pharmaceutical Research Division Collegeville PA, USA
3Present address: Harvard University School of Public Health Boston, MA, USA
The possibility that selection of an initiating agent could have a significant impact on the ability to detect subsequent promoting activity of peroxisome proliferators was examined. Initiation was achieved by established methods using 2-acetylaminofluorene (2-AAF: 0.02% in diet for 8 weeks) or diethylnitrosamine (DEN; 150 mg/kg body wt by single i.p. injection) in male F344 rats. Following initiation, the peroxisome proliferators WY-14,643 or clofibrate were each fed (0.1% of diet) for up to 37 weeks. Both WY-14,643 and clofibrate lacked promoting activity, as measured by increases in the volume density of homogeneous basophilic foci and incidence or multiplicity of hepatocellular neoplasia following 2-AAF initiation compared to non-initiated controls. These negative results sharply contrasted with the observed promoting activity of dietary WY-14,643 and clofibrate following DEN initiation. Peroxisome proliferation, measured as induction of acyl-CoA oxidase activity, was consistently observed in peroxisome proliferator-fed rats despite prior initiation with 2-AAF or DEN. These results suggest that detection of promoting activity for peroxisome proliferators depends on selection of the initiating agent.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Ittrich, E. Deml, D. Oesterle, K. Kuttler, W. Mellert, S. Brendler-Schwaab, H. Enzmann, L. Schladt, P. Bannasch, T. Haertel, et al. Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report Toxicol Pathol, January 1, 2003; 31(1): 60 - 79. [Abstract] [PDF] |
||||
![]() |
C. Kaplanski, C. J. Pauley, T. G. Griffiths, T. T. Kawabata, and B. J. Ledwith Differentiation of Rat Oval Cells after Activation of Peroxisome Proliferator-activated Receptor {{alpha}}43 Cancer Res., February 1, 2000; 60(3): 580 - 587. [Abstract] [Full Text] |
||||
![]() |
M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643 Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rokos and B. J. Ledwith Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells J. Biol. Chem., May 16, 1997; 272(20): 13452 - 13457. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714. [Abstract] [Full Text] [PDF] |
||||



